Amicus Therapeutics, Inc.
FOLD
$6.83
$0.131.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 143.55% | 68.81% | 63.69% | 8.53% | 39.42% |
| Total Depreciation and Amortization | -6.46% | -2.60% | -1.09% | 71.36% | 66.44% |
| Total Amortization of Deferred Charges | 11.38% | -20.39% | -19.08% | -20.39% | -20.12% |
| Total Other Non-Cash Items | -33.76% | 91.91% | -33.63% | 6.28% | 38.78% |
| Change in Net Operating Assets | -6,384.34% | -34.32% | 186.71% | -608.06% | 101.36% |
| Cash from Operations | -213.24% | 40.10% | 240.65% | -64.34% | 104.28% |
| Capital Expenditure | 83.36% | 77.25% | 50.14% | 6.75% | 35.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.55% | -7.24% | -140.00% | -75.53% | 67.04% |
| Cash from Investing | 14.88% | -4.17% | -143.95% | -79.21% | 64.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.99% | 177.42% | -56.52% | -50.00% | -213,636.13% |
| Issuance of Common Stock | -93.90% | -47.60% | -96.68% | -31.04% | 2,781.23% |
| Repurchase of Common Stock | 47.09% | -18.96% | -40.10% | -30.57% | -321.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -86.64% | -51.65% | -103.62% | -70.08% | 1,373.97% |
| Foreign Exchange rate Adjustments | 179.54% | -129.75% | 96.41% | -220.50% | -121.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.14% | -52.90% | -100.89% | -414.15% | 87.39% |